title: How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2).
abstract: BACKGROUND: The randomised, double-blind, placebo-controlled Systolic Hypertension in Europe trial (Syst-Eur 1) proved that blood pressure (BP) lowering therapy starting with nitrendipine reduces the risk of cardiovascular complications in elderly patients with isolated systolic hypertension. In an attempt to confirm the safety of long-term antihypertensive therapy based on a dihydropyridine, the Syst-Eur patients remained in open follow-up after the end of Syst-Eur 1. This paper presents the second progress report of this follow-up study (Syst-Eur 2). It describes BP control and adherence to study medications. METHODS: After the end of Syst-Eur 1 all patients, treated either actively or with placebo, were invited either to continue or to start antihypertensive treatment with the same drugs as previously used in the active treatment arm. In order to reach the target BP (sitting SBP <150 mmHg), the first line agent, nitrendipine, could be associated with enalapril and/or hydrochlorothiazide. RESULTS: Of the 3787 eligible patients, 3516 (93%) entered Syst-Eur 2. At the last available visit, 72% of the patients were taking nitrendipine. SBP/DBP at entry in Syst-Eur 2 averaged 160/83 mmHg in the former placebo group and 151/80 mmHg in the former active-treatment group. At the last follow-up visit SBP/DBP in the patients previously randomised to placebo or active treatment had decreased by 16/5 mmHg and 7/5 mmHg, respectively. The target BP was reached by 74% of the patients. CONCLUSION: Substantial reductions in systolic BP may be achieved in older patients with isolated systolic hypertension with a treatment strategy starting with the dihydropyridine calcium-channel blocker, nitrendipine, with the possible addition of enalapril and/or hydrochlorothiazide.
authors.affiliation: Hypertensie en Cardiovasculaire Revalidatie Eenheid, Katholieke Universiteit Leuven, Leuven, Belgium. Thijs@med.kuleuven.ac.be
authors.forename: Lutgarde
authors.initials: L
authors.lastname: Thijs
authors.forename: Jan A
authors.initials: JA
authors.lastname: Staessen
authors.forename: Sonia
authors.initials: S
authors.lastname: Beleva
authors.forename: Willem H
authors.initials: WH
authors.lastname: Birkenhäger
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Bulpitt
authors.forename: Hilde
authors.initials: H
authors.lastname: Celis
authors.forename: Astrid E
authors.initials: AE
authors.lastname: Fletcher
authors.forename: Rumjana
authors.initials: R
authors.lastname: Kermova
authors.forename: Gastone
authors.initials: G
authors.lastname: Leonetti
authors.forename: Tovio
authors.initials: T
authors.lastname: Laks
authors.forename: Stefan
authors.initials: S
authors.lastname: Mantov
authors.forename: Choudomir
authors.initials: C
authors.lastname: Nachev
authors.forename: Cinzia
authors.initials: C
authors.lastname: Sarti
authors.forename: Jaakko
authors.initials: J
authors.lastname: Tuomilehto
authors.forename: Robert H
authors.initials: RH
authors.lastname: Fagard